diversity | pharmaphorum

Monday 19 May 2025

Channels

Content type

Categories

Categories

Sort by

Order

diversity

Patients

diversity

Action by FDA ensures trial sponsors must consider diversity

Pharma has recognised that there is a problem with diversity in clinical trials, but has so far struggled to successfully achieve real change.

News

diversity in clinical trials

FDA reveals diversity action plan guide for clinical trials

The FDA has published its long-awaited update to guidance to make sure clinical trials more closely reflect the range of patients that might be treated with a new therapy in the real world.

News

clinical trial diversity

Mistrust in healthcare is hitting clinical trial enrolment

A survey of pharma industry executives has found that a third of them believe mistrust in the healthcare system has become a significant barrier to getting a diverse range of people to sign

Patients

adaptive EDI strategies

Sponsored

The case for adaptive EDI strategies in the UK

Clinical research in the UK is on a mission to ensure everyone, regardless of who they are, can participate.

Patients

diversity and inclusion

Operationalising diversity through site and patient engageme...

Most sponsors are aware of the benefits that may arise from increasing the diversity of clinical trial patient populations.

R&D

journey to diversity

On a journey to diverse, inclusive, and more efficient rare ...

Although orphan drugs represent a sizeable portion of new drug approvals,1most rare diseases still lack effective treatment.